Literature DB >> 10085467

The dim light melatonin onset, melatonin assays and biological rhythm research in humans.

A J Lewy1.   

Abstract

The most useful marker for human circadian phase position is the dim light melatonin onset (DLMO). This is optimally obtained by sampling blood or saliva in the evening at intervals of 30 min or less. Ambient light intensity should not exceed 30-50 lx. For many years, the DLMO was determined mainly with the 'gold standard' GCMS technique for measuring melatonin in human plasma. However, new and improved RIAs now provide the requisite sensitivity and accuracy (specificity) for detecting the time that low daytime levels begin to increase in the evening: the lower the operational threshold for the DLMO, the more reliable it is as a phase marker.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085467     DOI: 10.1159/000014573

Source DB:  PubMed          Journal:  Biol Signals Recept        ISSN: 1422-4933


  17 in total

1.  Late evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debt.

Authors:  Tali Gorfine; Nava Zisapel
Journal:  Hum Brain Mapp       Date:  2009-02       Impact factor: 5.038

Review 2.  Optimizing sleep in older adults: treating insomnia.

Authors:  Alexandra M Wennberg; Sarah L Canham; Michael T Smith; Adam P Spira
Journal:  Maturitas       Date:  2013-06-07       Impact factor: 4.342

3.  Altered resting-state activity in seasonal affective disorder.

Authors:  Ahmed Abou Elseoud; Juuso Nissilä; Anu Liettu; Jukka Remes; Jari Jokelainen; Timo Takala; Antti Aunio; Tuomo Starck; Juha Nikkinen; Hannu Koponen; Yu-Feng Zang; Osmo Tervonen; Markku Timonen; Vesa Kiviniemi
Journal:  Hum Brain Mapp       Date:  2012-09-15       Impact factor: 5.038

4.  Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep.

Authors:  Suzanne E Goldman; Karen W Adkins; M Wade Calcutt; Melissa D Carter; Robert L Goodpaster; Lily Wang; Yaping Shi; Helen J Burgess; David L Hachey; Beth A Malow
Journal:  J Autism Dev Disord       Date:  2014-10

5.  Relationships between circadian measures, depression, and response to antidepressant treatment: A preliminary investigation.

Authors:  Leslie M Swanson; Helen J Burgess; Edward D Huntley; Holli Bertram; Ann Mooney; Jennifer Zollars; Richard Dopp; Robert Hoffmann; Roseanne Armitage; J Todd Arnedt
Journal:  Psychiatry Res       Date:  2017-03-08       Impact factor: 3.222

6.  Daily Rhythm in Plasma N-acetyltryptamine.

Authors:  Peter S Backlund; Henryk F Urbanski; Mark A Doll; David W Hein; Marjan Bozinoski; Christopher E Mason; Steven L Coon; David C Klein
Journal:  J Biol Rhythms       Date:  2017-05-03       Impact factor: 3.182

7.  The Future of Sleep and Circadian Testing.

Authors:  David P White
Journal:  Sleep Med Clin       Date:  2009-09-01

Review 8.  Circadian rhythm disturbances in depression.

Authors:  Anne Germain; David J Kupfer
Journal:  Hum Psychopharmacol       Date:  2008-10       Impact factor: 1.672

9.  SMART DOCS: a new patient-centered outcomes and coordinated-care management approach for the future practice of sleep medicine.

Authors:  Clete A Kushida; Deborah A Nichols; Tyson H Holmes; Ric Miller; Kara Griffin; Chia-Yu Cardell; Pamela R Hyde; Elyse Cohen; Rachel Manber; James K Walsh
Journal:  Sleep       Date:  2015-02-01       Impact factor: 5.849

10.  Chronotype differences in circadian rhythms of temperature, melatonin, and sleepiness as measured in a modified constant routine protocol.

Authors:  Leon Lack; Michelle Bailey; Nicole Lovato; Helen Wright
Journal:  Nat Sci Sleep       Date:  2009-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.